The renoprotective effect of Tibolone in sepsis-induced acute kidney injury
Biomedical Papers · 2024
DOI: 10.5507/bp.2024.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Papers, 2024. Verfasst von Ejder Saylav Bora und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey. Hauptthemen laut MEDLINE: Sepsis, Acute Kidney Injury, Norpregnenes, Sirtuin 1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
INTRODUCTION: Sepsis-induced acute kidney injury (AKI) remains a major challenge in intensive care, contributing significantly to morbidity and mortality. Tibolone, known for its neuroprotective and hormonal properties, has not been explored for its potential in AKI management. This study investigates the protective effects of Tibolone and its underlying mechanisms involving Sirtuin-1 (SIRT1) and Yes-Associated Protein (YAP) in a rat sepsis model. MATERIALS AND METHODS: Thirty-six female Wistar albino rats underwent cecal ligation and puncture (CLP) to induce sepsis. They were randomly assigned to control, CLP+Saline, and CLP+Tibolone groups. Tibolone was administered intraperitoneally. Biomarkers, including Sirtuin (SIRT1), Yes-associated protein (YAP), Tumor necrosis factor (TNF-α), High mobility group box 1 (HMGB1), malondialdehyde (MDA), creatinine, and urea, were assessed. Histopathological examination evaluated renal damage. RESULTS: Tibolone administration significantly reduced plasma TNF-α, HMGB1, MDA, creatinine, and urea levels compared to the CLP+Saline group. Moreover, Tibolone elevated SIRT1 and YAP levels in kidney tissues. Histopathological examination demonstrated a significant decrease in tubular epithelial necrosis, luminal debris, dilatation, hemorrhage, and interstitial inflammation in Tibolone-treated rats. CONCLUSION: This study unveils the protective role of Tibolone against sepsis-induced AKI in rats. The improvements in inflammatory and oxidative biomarkers and histological evidence suggest Tibolone's potential as a therapeutic intervention in sepsis-associated kidney injury. The upregulation of SIRT1 and YAP indicates their involvement in Tibolone's renoprotective mechanisms. Further investigations are warranted to explore Tibolone's translational potential in human sepsis-induced AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey.
- Department of Pediatrics, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey.
- Depatment of Physiology, Faculty of Medicine, Demiroglu Bilim University Istanbul, Turkey.
Zitieren
APA
Bora, E. S., Arda, D. B., & Erbas, O. (2024). The renoprotective effect of Tibolone in sepsis-induced acute kidney injury. Biomedical Papers. https://doi.org/10.5507/bp.2024.016
Vancouver
Bora ES, Arda DB, Erbas O. The renoprotective effect of Tibolone in sepsis-induced acute kidney injury. Biomedical Papers. 2024. doi:10.5507/bp.2024.016
BibTeX
@article{Bora2024,
author = {Bora, Ejder Saylav and Arda, Duygu Burcu and Erbas, Oytun},
title = {The renoprotective effect of Tibolone in sepsis-induced acute kidney injury},
journal = {Biomedical Papers},
year = {2024},
doi = {10.5507/bp.2024.016}
}
EUVIMED